Loading stock data…
Nephros (NEPH)
$4.36+0.29 (+7.13%)
Market ClosedLast close Sep 8
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nephros, Inc. in the Healthcare sector is trading at $4.36 with a market capitalization of $35M. Wall Street consensus targets $6.25 (3 analysts), implying a +43.3% move over the next 12 months. The stock is currently 32% below its 52-week high of $6.42, remaining 11.5% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +43.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.21M↑ | $4.73M↓ | $4.76M↑ | $4.42M↓ | $4.88M |
| Gross Profit | $2.99M↑ | $2.76M↓ | $2.92M↑ | $2.79M↓ | $3.15M |
| Operating Income | $97,000↑ | $18,000↓ | $314,000↑ | $248,000↓ | $566,000 |
| Net Income | $140,000↑ | $62,000↓ | $337,000↑ | $237,000↓ | $558,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$34.74M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.25%
Volume
Today's trading volume
17,808
Recent News
Nephros (NEPH) Q2 2026 Earnings Call Transcript
Service revenue nearly tripled as core filter business accelerated.
Nephros, Inc. Q2 2026 Earnings Call Summary
Moby summary of Nephros, Inc.'s Q2 2026 earnings call
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...
Nephros Inc (NEPH) posts a 36% revenue jump to $6 million and a 400% net income increase, driven by broad-based growth and a one-time tariff refund.
US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
Shareholders of Nephros, Inc. ( NASDAQ:NEPH ) will be pleased this week, given that the stock price is up 15% to...
Nephros, Inc. Q1 2026 Earnings Call Summary
Moby summary of Nephros, Inc.'s Q1 2026 earnings call